Mira Pharmaceuticals SG&A Expense (TTM) Trends

Mira Pharmaceuticals Inc (MIRA)

1.16 +0.09 (+8.41%) USD | NASDAQ | Sep 27, 16:00

1.12 -0.04 (-3.45%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2022. Upgrade now.

Date	Value
June 30, 2024	6.936M
March 31, 2024	6.891M
December 31, 2023	6.500M
September 30, 2023	3.882M

Date	Value
June 30, 2023	2.473M
March 31, 2023	2.992M
December 31, 2022	2.995M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

2.473M

Minimum

Jun 2023

6.936M

Maximum

Jun 2024

4.667M

Average

3.882M

Median

Sep 2023

SG&A Expense (TTM) Benchmarks